CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis
about
Decreased plasma levels of soluble CD18 link leukocyte infiltration with disease activity in spondyloarthritisMonocyte Heterogeneity: Consequences for Monocyte-Derived Immune CellsRecent advances in understanding and managing psoriatic arthritisMyeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts.Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts.Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study.Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion.Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).Increased generation of TRAP expressing multinucleated giant cells in patients with granulomatosis with polyangiitis.Biomarkers to Diagnose Early Arthritis in Patients With Psoriasis.Interactions between the immune system and bone.The role of the immune system in the physiopathology of osteoporosisChronic Psoriatic Skin Inflammation Leads to Increased Monocyte Adhesion and AggregationNegative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signalingFunctional osteoclastogenesis: the baseline variability in blood donor precursors is not associated with age and gender.Ouabain inhibits monocyte activation in vitro: prevention of the proinflammatory mCD14(+)/CD16(+) subset appearance and cell-size progressionSources of heterogeneity in human monocyte subsets.Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis.Alliin Attenuated RANKL-Induced Osteoclastogenesis by Scavenging Reactive Oxygen Species through Inhibiting Nox1Is psoriatic arthritis a result of abnormalities in acquired or innate immunity?Macrophage subsets and osteoimmunology: tuning of the immunological recognition and effector systems that maintain alveolar bone.Transcriptomic network support distinct roles of classical and non-classical monocytes in human.Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis.Focal bone involvement in inflammatory arthritis: the role of IL17.Monocytic cell differentiation from band-stage neutrophils under inflammatory conditions via MKK6 activation.Clinical significance of monocyte heterogeneity.Circulating monocytes: an appropriate model for bone-related study.Emerging biomarkers in psoriatic arthritis.Biomarkers in psoriatic arthritis: a systematic literature review.CD16+ monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis.Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems.Osteoclastogenic potential of peripheral blood mononuclear cells in cleidocranial dysplasia.Autoimmune or Autoiflammatory? Bad to the Bone.Macrophage polarization and activation in response to implant debris: influence by "particle disease" and "ion disease"Peripheral blood mononuclear phagocytes from patients with chronic periodontitis are primed for osteoclast formation.The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence.ERBB signaling attenuates proinflammatory activation of nonclassical monocytes.Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Osteoclast Differentiation via the Ca2+ /NFATc1 Axis.Decreased tumour necrosis factor-α production by monocytes of granulomatosis with polyangiitis.
P2860
Q22000831-F98BF3ED-1660-4254-837A-E1B15385FA46Q26740174-DE5400A2-6575-48BB-B7CD-9DD6462FCE3AQ28076527-8C657AF1-0D72-413E-B1F7-65B6F9495654Q30278787-1F99C8A1-6D22-4323-B667-943CA74503C0Q30478264-150C987B-0CB0-4A06-9EEF-50BAE59E7A85Q33574203-9FE36896-17B4-4EE5-9C66-C01FE742B128Q33764331-30FB43E3-1F22-470F-8588-45AFCA76FF72Q34153144-7E87D8F3-0EBD-4998-B404-9E55A7766AFAQ34222920-B1525CBF-525D-4D00-B6D7-CAD0F55FFDBCQ34384535-D5D6D690-14B9-41A0-A65D-A357B9F2FD62Q34563661-4E500E9B-3FFE-4AF2-AFB9-0BF228BF2B5CQ35825391-D655ACC4-D96D-4EB7-87EA-F524C70D3A80Q36333478-E53FA33E-FA05-4427-90FC-229F6B88A144Q36390768-7F2513A4-B5A7-43C6-930C-951A374FA8C5Q36468037-718BEA17-B1A9-46E4-98E5-FF29D6410DDCQ36544723-684C7F78-5624-4C15-9F36-28FEBD5D60D5Q36891100-77EAB0CC-97E5-47FD-812B-87A379A1F1F8Q36935158-E1998B6F-6DFF-4B18-9BDD-66EDA4EE201DQ37115802-2C229F71-55D8-40A0-BA48-1EA27358B962Q37286542-7ACAF803-6996-45AF-93C0-9272F3453B20Q38004958-975545BF-0EBA-4CE1-B7FC-EB0C99242115Q38127779-65877FEF-0DD9-422B-8AC3-58FCE5154ED2Q38204490-F9B8FD3E-E176-481A-AFFA-A3D8D5DEF886Q38218977-F1DD0DD5-F78D-43FB-9F2E-BD5983449672Q38295616-DACD1F6B-C39F-4B47-B146-4CFB85E1877BQ38304270-F734CE5D-E864-4D21-8EBD-073350F78B42Q38411099-1D415A68-F60F-4711-941E-A77124DFB3C5Q38551006-6F64C6A3-8C6E-4EE9-8698-6ACFE013038AQ38646234-1F3F3C54-255A-42E4-BE18-A209B217F95CQ38715137-DD701E6E-CB0A-4316-894F-90DD0FFECC5FQ39584019-9AD20B2A-861A-45BB-8300-3E0A3109D380Q41921500-6A109AEE-2F01-4535-8BC1-E6A3B9761551Q41980849-00AAE659-F905-4098-92E5-4E13E9C4FEAFQ42095487-ADF22CFA-0406-40D7-BEDD-F5D96BC3AB44Q42696291-1E7E24A8-D8BE-40A6-89C1-EDC60C576861Q45272768-95E28B3E-B856-4E0E-A394-77780BEDBEAAQ49958269-F0BE5B66-4766-48D8-9A49-FC01FE3D5391Q51123571-7245B019-F494-408F-88C9-9A4A206F63CAQ51141211-75D45C2A-FE33-4233-BEF7-0A7A623F7CF0Q51719130-199B91ED-BD90-4140-B366-01507D17B280
P2860
CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis
@ast
CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis
@en
type
label
CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis
@ast
CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis
@en
prefLabel
CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis
@ast
CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis
@en
P2093
P2860
P356
P1476
CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis
@en
P2093
Changyong Feng
Christopher T Ritchlin
Edward M Schwarz
Michael Thullen
Tianmeng Shao
Yahui Grace Chiu
P2860
P2888
P356
10.1186/AR2915
P577
2010-01-26T00:00:00Z
P5875
P6179
1025585344